Literature DB >> 25354783

Identification of miR-145 targets through an integrated omics analysis.

Tai-Chung Huang1, Santosh Renuse, Sneha Pinto, Praveen Kumar, Yi Yang, Raghothama Chaerkady, Brian Godsey, Joshua T Mendell, Marc K Halushka, Curt I Civin, Luigi Marchionni, Akhilesh Pandey.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and protein synthesis. To characterize functions of miRNAs and to assess their potential applications, we carried out an integrated multi-omics analysis to study miR-145, a miRNA that has been shown to suppress tumor growth. We employed gene expression profiling, miRNA profiling and quantitative proteomic analysis of a pancreatic cancer cell line. In our transcriptomic analysis, overexpression of miR-145 was found to suppress the expression of genes that are implicated in development of cancer such as ITGA11 and MAGEA4 in addition to previously described targets such as FSCN1, YES1 and PODXL. Based on miRNA profiling, overexpression of miR-145 also upregulated other miRNAs including miR-124, miR-133b and miR-125a-3p, all of which are implicated in suppression of tumors and are generally co-regulated with miR-145 in other cancers. Using the SILAC system, we identified miR-145-induced downregulation of several oncoproteins/cancer biomarkers including SET, RPA1, MCM2, ABCC1, SPTBN1 and SPTLC1. Luciferase assay validation carried out on a subset of downregulated candidate targets confirmed them to be novel direct targets of miR-145. Overall, this multi-omics approach provided insights into miR-145-mediated tumor suppression and could be used as a general strategy to study the targets of individual miRNAs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25354783      PMCID: PMC4352311          DOI: 10.1039/c4mb00585f

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  80 in total

1.  Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer.

Authors:  Minyong Chen; Xiaofeng Xue; Feitong Wang; Yong An; Dong Tang; Yue Xu; Hui Wang; Zhongxu Yuan; Wentao Gao; Jishu Wei; Jingjing Zhang; Yi Miao
Journal:  Oncol Rep       Date:  2011-09-28       Impact factor: 3.906

2.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

3.  SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer.

Authors:  Takeshi Chiyomaru; Shuichi Tatarano; Kazumori Kawakami; Hideki Enokida; Hirofumi Yoshino; Nijiro Nohata; Miki Fuse; Naohiko Seki; Masayuki Nakagawa
Journal:  Prostate       Date:  2011-02-25       Impact factor: 4.104

4.  Effects of the miR-143/-145 microRNA cluster on the colon cancer proteome and transcriptome.

Authors:  Kerry M Bauer; Amanda B Hummon
Journal:  J Proteome Res       Date:  2012-08-27       Impact factor: 4.466

5.  A relationship between replication protein A and occurrence and prognosis of esophageal carcinoma.

Authors:  Yu Dahai; Sun Sanyuan; Lu Hong; Zhao Di; Zhou Chong
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

6.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

7.  Expression of SET, an inhibitor of protein phosphatase 2A, in renal development and Wilms' tumor.

Authors:  S G Carlson; E Eng; E G Kim; E J Perlman; T D Copeland; B J Ballermann
Journal:  J Am Soc Nephrol       Date:  1998-10       Impact factor: 10.121

8.  Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.

Authors:  Chang-Qi Zhu; Svetlana N Popova; Ewan R S Brown; Dalia Barsyte-Lovejoy; Roya Navab; Warren Shih; Ming Li; Ming Lu; Igor Jurisica; Linda Z Penn; Donald Gullberg; Ming-Sound Tsao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-28       Impact factor: 11.205

9.  MicroRNA biogenesis is required for mouse primordial germ cell development and spermatogenesis.

Authors:  Katsuhiko Hayashi; Susana M Chuva de Sousa Lopes; Masahiro Kaneda; Fuchou Tang; Petra Hajkova; Kaiqin Lao; Donal O'Carroll; Partha P Das; Alexander Tarakhovsky; Eric A Miska; M Azim Surani
Journal:  PLoS One       Date:  2008-03-05       Impact factor: 3.240

10.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.

Authors:  Joachim Silber; Daniel A Lim; Claudia Petritsch; Anders I Persson; Alika K Maunakea; Mamie Yu; Scott R Vandenberg; David G Ginzinger; C David James; Joseph F Costello; Gabriele Bergers; William A Weiss; Arturo Alvarez-Buylla; J Graeme Hodgson
Journal:  BMC Med       Date:  2008-06-24       Impact factor: 8.775

View more
  8 in total

1.  miR-375 Regulates Invasion-Related Proteins Vimentin and L-Plastin.

Authors:  Lizandra Jimenez; Jihyeon Lim; Berta Burd; Thomas M Harris; Thomas J Ow; Nicole Kawachi; Thomas J Belbin; Ruth Angeletti; Michael B Prystowsky; Geoffrey Childs; Jeffrey E Segall
Journal:  Am J Pathol       Date:  2017-05-10       Impact factor: 4.307

Review 2.  MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer.

Authors:  Yiwei Li; Fazlul H Sarkar
Journal:  Int J Biol Sci       Date:  2016-01-28       Impact factor: 6.580

Review 3.  miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancer.

Authors:  Daojiang Li; Lu Xia; Miao Chen; Changwei Lin; Hao Wu; Yi Zhang; Songqing Pan; Xiaorong Li
Journal:  Oncotarget       Date:  2017-07-25

4.  Podocalyxin-like protein promotes gastric cancer progression through interacting with RUN and FYVE domain containing 1 protein.

Authors:  Qiaoming Zhi; Huo Chen; Fei Liu; Ye Han; Daiwei Wan; Zhihua Xu; Yuting Kuang; Jin Zhou
Journal:  Cancer Sci       Date:  2018-12-15       Impact factor: 6.716

Review 5.  ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer.

Authors:  David Vrana; Viktor Hlavac; Veronika Brynychova; Radka Vaclavikova; Cestmir Neoral; Jiri Vrba; Rene Aujesky; Marcel Matzenauer; Bohuslav Melichar; Pavel Soucek
Journal:  Int J Mol Sci       Date:  2018-03-15       Impact factor: 5.923

6.  Functional omics analyses reveal only minor effects of microRNAs on human somatic stem cell differentiation.

Authors:  Jessica Schira-Heinen; Agathe Czapla; Marion Hendricks; Andreas Kloetgen; Wasco Wruck; James Adjaye; Gesine Kögler; Hans Werner Müller; Kai Stühler; Hans-Ingo Trompeter
Journal:  Sci Rep       Date:  2020-02-24       Impact factor: 4.379

7.  Long non‑coding RNA FEZF1‑AS1 facilitates non‑small cell lung cancer progression via the ITGA11/miR‑516b‑5p axis.

Authors:  Heng Song; Hui Li; Xiaosong Ding; Minglei Li; Haitao Shen; Yuehong Li; Xianghong Zhang; Lingxiao Xing
Journal:  Int J Oncol       Date:  2020-10-29       Impact factor: 5.650

Review 8.  βII spectrin (SPTBN1): biological function and clinical potential in cancer and other diseases.

Authors:  Panyu Yang; Yanyan Yang; Pin Sun; Yu Tian; Fang Gao; Chen Wang; Tingyu Zong; Min Li; Ying Zhang; Tao Yu; Zhirong Jiang
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.